Literature DB >> 2469898

Statistical pitfalls in the analysis of age-related effects in antihypertensive therapy.

G D Murray1, E Lesaffre.   

Abstract

Much of the literature concerning age-related effects in antihypertensive therapy suffers from serious deficiencies in statistical design and analysis. The problems include those relating to the choice of a suitable control group, the measurement of response to treatment, response to baseline blood pressure, interpreting post hoc analyses, and the pooling of data from a number of related studies. These problems are discussed and we attempt to identify solutions that give a satisfactory balance between scientific validity and the real-life problems of conducting clinical trials. We conclude by outlining a protocol for future studies in this area.

Mesh:

Substances:

Year:  1988        PMID: 2469898

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  5 in total

Review 1.  Newer beta blockers and the treatment of hypertension.

Authors:  D McAreavey; R Vermeulen; J I Robertson
Journal:  Cardiovasc Drugs Ther       Date:  1991-06       Impact factor: 3.727

Review 2.  Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease.

Authors:  R N Brogden; E M Sorkin
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

3.  Ageing, and treatment of hypertension.

Authors:  J I Robertson
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 4.  Prognostic significance of blood pressure in the very old. Implications for the treatment decision.

Authors:  C J Bulpitt; A E Fletcher
Journal:  Drugs Aging       Date:  1994-09       Impact factor: 3.923

5.  Serotonin-induced platelet aggregation predicts the antihypertensive response to serotonin receptor antagonists.

Authors:  G Gleerup; B Persson; T Hedner; K Winther
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.